Position in PFE
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$1,103,706
-$199,486 QoQ
Shares Held
45,835
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,274
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mirador Capital Partners LP holds $28,463,151 across 9 Drug Manufacturers - General names. PFE ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,762 | $17,303,269 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
48,795 | $2,811,567 | |
| 3 | LLY |
ELI LILLY & Co
|
1,657 | $1,987,455 | |
| 4 | JNJ |
Johnson & Johnson
|
7,410 | $1,881,917 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
14,099 | $1,781,267 | |
| 6 | PFE |
Pfizer Inc
This page
|
45,835 | $1,103,706 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,882 | $755,837 | |
| 8 | AMGN |
Amgen Inc
|
1,410 | $510,589 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,103,706 | 45,835 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $1,303,192 | 46,410 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $1,140,320 | 45,796 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,234,760 | 48,460 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,177,458 | 48,575 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $935,375 | 36,913 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $954,231 | 35,968 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $995,999 | 34,416 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $272,581 | 9,742 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $251,165 | 9,051 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $2,350,617 | 81,647 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,539,594 | 76,563 | Shares | Sole | 2023-10-05 | |
| 2023-06-30 | $2,790,247 | 76,070 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $369,362 | 9,053 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $794,988 | 15,515 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $677,754 | 15,488 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $865,566 | 16,509 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $858,191 | 16,577 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,003,672 | 16,997 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $949,660 | 22,080 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $865,122 | 22,092 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $791,444 | 21,845 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,977,764 | 53,729 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $1,821,492 | 49,632 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,966,841 | 60,148 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,712,585 | 52,469 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||